sonam sinha

Employment

• B.V.Patel Pharmaceutical Education Research and Development (PERD)Centre Women Scientist -A (WOS-A), (Pursuing Ph.D.)
  2018 - 2021
• Central Drug Research Institute Research Fellow in DBT funded project entitled as “Studies on effect of different herbal preparations on wound healing and angiogenesis”.
  2015 - 2015
• Central Drug Research Institute Research fellow under his supervision in a DST funded project entitled as “Novel genetic and epigenetic targets for breast cancer prevention and therapy: A mechanistic approach with bioactive dietary supplements
  2012 - 2015
• Oncquest Laboratories Limited Industrial Trainee sponsored by Biotech Consortium India Limited (BCIL) under its Biotech Industrial Training Programme (BITP)
  2012 - 2012

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Binding Insight of Anti-HIV Phytocompounds with Prime Targets of HIV: A Molecular Dynamics Simulation Analysis.
  Current HIV research 2020 DOI: 10.2174/1570162x18666200129112509
  +Save
• Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: An in silico and in vitro study.
  International journal of biological macromolecules 2019 DOI: 10.1016/j.ijbiomac.2019.08.061
  +Save
• Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds.
  Journal of biomolecular structure & dynamics 2019 DOI: 10.1080/07391102.2019.1615002
  +Save
• Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
  Journal of biomolecular structure & dynamics 2018 DOI: 10.1080/07391102.2018.1509732
  +Save
• Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
  Journal of ethnopharmacology 2018 DOI: 10.1016/j.jep.2018.02.006
  +Save
• Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
  Journal of biomolecular structure & dynamics 2018 DOI: 10.1080/07391102.2017.1420489
  +Save
• Lung Cancer Stem Cells: An Epigenetic Perspective.
  Current cancer drug targets 2018 DOI: 10.2174/1568009617666170206104623
  +Save
• Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
  The international journal of biochemistry & cell biology 2016 DOI: 10.1016/j.biocel.2016.05.014
  +Save
• Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis.
  Scientific reports 2016 DOI: 10.1038/srep21860
  +Save
• Epigenetic targets in cancer and aging: dietary and therapeutic interventions.
  Expert opinion on therapeutic targets 2016 DOI: 10.1517/14728222.2016.1132702
  +Save